retatrutide triple agonist gip glp-1 glucagon phase 2 obesity trial 3: 28.7% Weight Loss (2026) Retatrutide for weight loss: Study
Pay in 4 interest-free payments of $6.09 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27



/assets/production/practices/bb098bde1976b73281d3b963c3dfa64815de4cfc/images/2780379.jpeg)










-1775582746855.png&w=3840&q=75)



.webp)





![PDF] Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial](https://figures.semanticscholar.org/a9800c8f0dc40d6d18a09ab6d2f14e71a42af380/7-Figure2-1.png)


